Caption Management’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-400,000
Closed -$4.52M 1574
2025
Q4
$4.52M Sell
400,000
-453,600
-53% -$5.62M 0.03% 552
2025
Q3
$12.8M Buy
853,600
+73,600
+9% +$1.07M 0.1% 217
2025
Q2
$11M Buy
780,000
+755,000
+3,020% +$13.5M 0.12% 183
2025
Q1
$601K Sell
25,000
-81,800
-77% -$2.88M 0.01% 1057
2024
Q4
$3.99M Buy
106,800
+41,400
+63% +$1.93M 0.04% 441
2024
Q3
$3.27M Buy
+65,400
New +$2.54M 0.05% 416
2024
Q2
Sell
-48,000
Closed -$2.63M 1163
2024
Q1
$2.63M Buy
48,000
+23,000
+92% +$1.14M 0.04% 461
2023
Q4
$1.07M Buy
+25,000
New +$777K 0.01% 786

Other funds holding BHVN

Caption Management's BHVN Position: Q2 2026 in Review

Caption Management increased its Biohaven (BHVN) stake by 92% in Q2 2026, buying an estimated $750K and bringing the position to 145,000 shares worth $2.16M. The position accounts for 0.01% of the portfolio, ranked #880.

Caption Management first reported a position in BHVN in Q4 2023 and has held it in 8 quarters since. The position peaked at $9.42M in Q3 2025. 296 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Caption Management held 145,000 shares of Biohaven worth $2.16M as of Q2 2026.
  • Caption Management bought 69,661 Biohaven shares in Q2 2026, an estimated $750K.
  • Biohaven made up 0.01% of Caption Management's portfolio in Q2 2026, its #880 holding.
  • Caption Management first reported a position in Biohaven in Q4 2023 and has held it in 8 quarters since.
  • Caption Management's Biohaven position peaked at $9.42M in Q3 2025.
  • 296 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.